VeriMomsalicyloyl phytosphingosine hamilelikte güvenli mi?
No harmonised CLP classification, no SCCS or CIR reproductive safety assessment located, and no animal or human reproductive/teratology data were identified for salicyloyl phytosphingosine; published literature describes topical skin effects (procollagen, barrier repair) but not reproductive toxicity. The ingredient is a cosmetic sphingolipid derivative used at low % in topical products, so systemic exposure from normal cosmetic use is expected to be low but measurable. Sources: PubMed (dermatology/skin studies), PubChem/Chemical databases, EWG entry. ([pubmed.ncbi.nlm.nih.gov](https://pubmed.ncbi.nlm.nih.gov/18489360/))
Pregnancy-safe products containing salicyloyl phytosphingosine
Related ingredients
Frequently asked questions
- salicyloyl phytosphingosine hamilelikte güvenli mi?
- No harmonised CLP classification, no SCCS or CIR reproductive safety assessment located, and no animal or human reproductive/teratology data were identified for salicyloyl phytosphingosine; published literature describes topical skin effects (procollagen, barrier repair) but not reproductive toxicity. The ingredient is a cosmetic sphingolipid derivative used at low % in topical products, so systemic exposure from normal cosmetic use is expected to be low but measurable. Sources: PubMed (dermatology/skin studies), PubChem/Chemical databases, EWG entry. ([pubmed.ncbi.nlm.nih.gov](https://pubmed.ncbi.nlm.nih.gov/18489360/))
- salicyloyl phytosphingosine emzirirken güvenli mi?
- No data on transfer into breast milk or breastfeeding-associated studies were found; with no reproductive or developmental toxicity signals and low expected systemic absorption from topical cosmetics, hazard is not indicated. Exposure is considered low but measurable as for pregnancy. ([pubmed.ncbi.nlm.nih.gov](https://pubmed.ncbi.nlm.nih.gov/18489360/))
- salicyloyl phytosphingosine bebek cildi için güvenli mi?
- No infant‑specific toxicity data were identified. Following the user's scoring rules, because the ingredient has measurable (though low) dermal exposure in adults (see above) baby exposure is increased by +1 due to immature barrier and higher surface‑area‑to‑weight; there are still no data suggesting developmental/dermal hazard for infants. The literature describes topical skin benefits (barrier repair, anti‑inflammatory) rather than harm. ([pubmed.ncbi.nlm.nih.gov](https://pubmed.ncbi.nlm.nih.gov/18489360/))
- VeriMom salicyloyl phytosphingosine nasıl puanlıyor?
- VeriMom salicyloyl phytosphingosine'yi EU CosIng, ECHA sınıflandırmaları ve PubMed çalışmalarına göre 93/100 (bilinen risk yok) olarak puanlar.
- Hamilelikte salicyloyl phytosphingosine yerine neler kullanılabilir?
- Benzer işlevli ve bilinen riski olmayan alternatifleri içeren listemize bakın.
Her etiketi 2 saniyede kontrol et
VeriMom'u ücretsiz indirin — herhangi bir ürünü tarayın ve hamilelik güvenlik puanını anında görün.
Tıbbi Sorumluluk Reddi
Bu bilgiler yalnızca eğitim amaçlıdır ve tıbbi tavsiye niteliği taşımaz. Güvenlik puanları kamuya açık verilere dayanmaktadır ve tüm riskleri yansıtmayabilir. Hamilelik veya emzirme döneminde herhangi bir ürünü kullanmadan önce her zaman sağlık uzmanınıza danışın.